The Future of Glaucoma Care: Protecting the Optic Nerve
Overview
Dr. Louis R. Pasquale highlights the evolving understanding of glaucoma as a multifactorial disease requiring expanded focus beyond intraocular pressure (IOP) management to optic nerve protection. Advances in genetics, metabolism, imaging, and novel therapies promise to improve diagnosis, risk stratification, and treatment outcomes.
Background
Glaucoma is a heterogeneous optic neuropathy characterized by progressive retinal ganglion cell loss and visual field damage. Traditional management has centered on lowering IOP, the main modifiable risk factor. However, many patients continue to progress despite controlled IOP, underscoring the need to address upstream pathogenic mechanisms and optic nerve vulnerability. Dr. Pasquale’s work integrates genetic, vascular, structural, and systemic factors to redefine glaucoma care and improve long-term patient outcomes.
Data Highlights
Key future directions discussed include: systemic biomarkers via serum proteomics, advanced optic nerve imaging modalities, remote IOP monitoring for non-ambulatory spikes, genetic engineering to correct trabecular outflow defects, mitochondrial-targeted therapies, and polygenic risk scores for personalized management.
Key Findings
- Glaucoma is influenced by both ocular and extraocular factors, necessitating a broader clinical focus beyond IOP reduction.
- Systemic biomarkers and dynamic optic nerve imaging may enable monitoring of disease activity and treatment efficacy.
- Remote IOP profiling can detect harmful pressure spikes missed during office visits, improving risk assessment.
- Emerging therapies aim to fix trabecular outflow pathways genetically and enhance mitochondrial function for direct optic nerve protection.
- Polygenic risk scores and multiomic approaches hold promise for precision medicine in glaucoma diagnosis and management.
- Future clinical skills may include genetic data integration and surgical techniques for direct optic nerve interventions.
Clinical Implications
Clinicians should anticipate incorporating genetic and systemic biomarkers into glaucoma risk stratification and monitoring. Advanced imaging and remote IOP measurement tools will enhance early detection and individualized treatment adjustments. Training in minimally invasive surgery and genetic therapies may become essential as novel neuroprotective strategies evolve.
Conclusion
Expanding glaucoma care to encompass optic nerve protection through multidisciplinary approaches and innovative technologies offers hope for improved patient outcomes. Dr. Pasquale’s insights underscore the importance of evolving clinical paradigms to meet these challenges.
References
- Pasquale LR, 2026 AGS Lecture -- The Future of Glaucoma Care: Protecting the Optic Nerve
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.